News
Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...
The complaint argues Kennedy’s actions to remove the COVID vaccine from the CDC's immunization schedule for pregnant people ...
One analyst described Cogent’s data as a “home run scenario” for bezuclastinib, which the company is positioning as a ...
The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results